Benet 75 mg Tablets Special Drug Use Surveillance: Long-term Use (12-month Treatment Survey)
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2016
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- Sponsors Takeda
- 13 Jul 2016 Status changed from active, no longer recruiting to completed.
- 25 Aug 2015 Planned End Date changed from 1 Oct 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov.
- 25 Aug 2015 Planned primary completion date changed from 1 Oct 2014 to 1 Apr 2016 as reported by ClinicalTrials.gov.